Since our functional experiments supported that reduced VDAC2 expression was critical for GSC phenotypic transition from NSTCs, examining VDAC2 expression in glioma specimens is of great diagnostic value to predict the possibility of GSC phenotypic conversion, thus indicates the chance of therapeutic resistance and patient outcome. The gene discussed is VDAC2; the disease is glioma.